FGF10 Signaling differences between type I pleuropulmonary blastoma and congenital cystic adenomatoid malformation
Guillaume Lezmi(Hôpital Necker-Enfants Malades), Christophe Delacourt(Hôpital Necker-Enfants Malades)
Cited by 72
Related Papers
Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy
|New England Journal of Medicine|2023|129
Congenital cystic adenomatoid malformations of the lung: an epithelial transcriptomic approach
|Respiratory Research|2020|66
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPE
|The Journal of Allergy and Clinical Immunology In Practice|2025|14
Restored Cytokine-Producing Capacities of Mucosal-associated Invariant T Cells in Pediatric Cystic Fibrosis Patients Treated with Elexacaftor/Tezacaftor/Ivacaftor
|American Journal of Respiratory and Critical Care Medicine|2024|2